What is Vaxcyte, Inc.'s trading assets?

Vaxcyte, Inc. (PCVX) reported trading assets of $1.48B in Q1 2026.

How has Vaxcyte, Inc.'s trading assets changed year-over-year?

Vaxcyte, Inc.'s trading assets increased by 11.4% year-over-year, from $1.32B to $1.48B.

What does trading assets mean?

Securities and other financial instruments held for short-term trading purposes, measured at fair value with changes flowing through the income statement.

Vaxcyte, Inc. PCVX Trading assets

Trading assets at other companies

ModernaMRNA

——

Other financials

Income statement

See full

Operating income-$345.9M-91.3%

Net income-$320.6M-128%

EPS (diluted)-$2.30-121%

Balance sheet

See full

Cash & equivalents$262.3M-24.7%

Total debt$116.3M+33.5%

Total equity$3.0B-6.4%

Total assets$3.3B-0.9%

Cash flow

See full

Operating cash flow-$280.6M-68.8%

CapEx$2.1M-61.2%

Free cash flow-$282.7M-64.7%

Valuation

See full

Market cap$7.43B+72.0%

Enterprise value$7.28B+78.6%

Returns & leverage

See full

Return on equity-30.6%+37.9pp

Debt / equity0×0.0×

Current ratio7.5×-10.2×

Where this comes from

Reported directly by Vaxcyte, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue.

The official record: Vaxcyte, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vaxcyte, Inc.'s trading assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Vaxcyte, Inc.'s trading assets?: Vaxcyte, Inc. (PCVX) reported trading assets of $1.48B in Q1 2026.
How has Vaxcyte, Inc.'s trading assets changed year-over-year?: Vaxcyte, Inc.'s trading assets increased by 11.4% year-over-year, from $1.32B to $1.48B.
What does trading assets mean?: Securities and other financial instruments held for short-term trading purposes, measured at fair value with changes flowing through the income statement.